Janete Vettorazzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Janete Vettorazzi has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
- Jose Guilherme Cecatti
Department of Obstetrics and Gynecology, University of Campinas, Brazil
8 shared publications - Renato Teixeira Souza
Department of Obstetrics and Gynecology, University of Campinas, 101 Alexander Fleming Street, Campinas, Sao Paulo, Brazil
7 shared publications - Maria Laura Costa
Department of Obstetrics and Gynecology University of Campinas Campinas Brazil
6 shared publications - Iracema Mattos Paranhos Calderon
Obstetrics and Gynecology Botucatu State of São Paulo São Paulo State University - Botucatu Campus
5 shared publications - Débora Farias Leite
Department of Obstetrics and Gynaecology, University of Campinas (UNICAMP) School of Medical Sciences, Campinas, SP, Brazil
4 shared publications - Jussara Mayrink
Department of Obstetrics and Gynecology Federal University of Minas Gerais (UFMG) Belo Horizonte Minas Gerais Brazil
4 shared publications
Latest Publications
- Open Access
- 20 June 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (3) , 1328-1339
Developing a social vulnerability index for antenatal care screening of risk for adverse maternal and perinatal outcomes
Objective: Social determinants of health influence maternal and perinatal outcomes, yet tools to operationalize these risks in clinical care remain scarce. We aimed to study social determinants in Brazilian pregnant women and develop a social vulnerability index (SVI) that could correlate with pregnancy and perinatal outcomes. Methods: The present study was a secondary analysis of 1565 low‐risk nulliparous women enrolled in two Brazilian cohort studies. We selected vulnerability indicators from sociodemographic data and tested the performance and risk association of multiple SVI models with any adverse outcome (preterm birth, gestational diabetes mellitus, pre‐eclampsia, small or large for gestational age, low 5‐min Apgar score, neonatal intubation, neonatal intensive care unit admission, fetal or neonatal death) using chi‐square tests, logistic regression, and receiver operating characteristic analysis. Results: Advanced maternal age, non‐white ethnicity, and exclusive publicly funded antenatal care were the most consistent vulnerability predictors of adverse outcomes. The final three‐variable SVI demonstrated a significant dose–response gradient, with maternal adverse outcomes increasing from 16.4% (no vulnerabilities) to 43.8% (3 vulnerabilities) and perinatal adverse outcomes rising from 22.1% to 35.6%. The model presented a sensitivity of 64.71%, a specificity of 42.56%, a positive predictive value of 47.46% and a negative predictive value of 60.07% for any adverse outcome. Conclusion: The three‐variable SVI offers a simple, reproducible, and context‐adapted screening tool for primary care. Either for individual or population screening, it can be easily combined with clinical risk assessment, targeting those who may benefit from equity‐oriented maternal health strategies.
- 20 June 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (3) , 1328-1339
Open AccessDeveloping a social vulnerability index for antenatal care screening of risk for adverse maternal and perinatal outcomes
Objective: Social determinants of health influence maternal and perinatal outcomes, yet tools to operationalize these risks in clinical care remain scarce. We aimed to study social determinants in Brazilian pregnant women and develop a social vulnerability index (SVI) that could correlate with pregnancy and perinatal outcomes. Methods: The present study was a secondary analysis of 1565 low‐risk nulliparous women enrolled in two Brazilian cohort studies. We selected vulnerability indicators from sociodemographic data and tested the performance and risk association of multiple SVI models with any adverse outcome (preterm birth, gestational diabetes mellitus, pre‐eclampsia, small or large for gestational age, low 5‐min Apgar score, neonatal intubation, neonatal intensive care unit admission, fetal or neonatal death) using chi‐square tests, logistic regression, and receiver operating characteristic analysis. Results: Advanced maternal age, non‐white ethnicity, and exclusive publicly funded antenatal care were the most consistent vulnerability predictors of adverse outcomes. The final three‐variable SVI demonstrated a significant dose–response gradient, with maternal adverse outcomes increasing from 16.4% (no vulnerabilities) to 43.8% (3 vulnerabilities) and perinatal adverse outcomes rising from 22.1% to 35.6%. The model presented a sensitivity of 64.71%, a specificity of 42.56%, a positive predictive value of 47.46% and a negative predictive value of 60.07% for any adverse outcome. Conclusion: The three‐variable SVI offers a simple, reproducible, and context‐adapted screening tool for primary care. Either for individual or population screening, it can be easily combined with clinical risk assessment, targeting those who may benefit from equity‐oriented maternal health strategies.
- Open Access
- 23 February 2026
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 48
Diagnosis and management of mirror syndrome: a case series with emphasis on the potential role of the sFLT-1/PlGF ratio in clinical practice
Objective: To characterize the maternal clinical, ultrasound, and laboratory parameters, maternal and perinatal outcomes of mirror syndrome, and to discuss the role of sFlt-1/PlGF biomarkers in diagnosis and management. Methods: We conducted a case series including all cases of mirror syndrome diagnosed at a tertiary reference center in Brazil. Clinical, laboratory, ultrasound, and biomarker […] Abstract Objective: To characterize the maternal clinical, ultrasound, and laboratory parameters, maternal and perinatal outcomes of mirror syndrome, and to discuss the role of sFlt-1/PlGF biomarkers in diagnosis and management. Methods: We conducted a case series including all cases of mirror syndrome diagnosed at a tertiary reference center in Brazil. Clinical, laboratory, ultrasound, and biomarker […]
- 23 February 2026
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 48
Open AccessDiagnosis and management of mirror syndrome: a case series with emphasis on the potential role of the sFLT-1/PlGF ratio in clinical practice
Objective: To characterize the maternal clinical, ultrasound, and laboratory parameters, maternal and perinatal outcomes of mirror syndrome, and to discuss the role of sFlt-1/PlGF biomarkers in diagnosis and management. Methods: We conducted a case series including all cases of mirror syndrome diagnosed at a tertiary reference center in Brazil. Clinical, laboratory, ultrasound, and biomarker […] Abstract Objective: To characterize the maternal clinical, ultrasound, and laboratory parameters, maternal and perinatal outcomes of mirror syndrome, and to discuss the role of sFlt-1/PlGF biomarkers in diagnosis and management. Methods: We conducted a case series including all cases of mirror syndrome diagnosed at a tertiary reference center in Brazil. Clinical, laboratory, ultrasound, and biomarker […]
- Open Access
- 7 February 2026
- Published by Georg Thieme Verlag KG in Revista Brasileira de Cirurgia Plástica (RBCP) – Brazilian Journal of Plastic Surgery
- Vol. 41 (CP)
Integração de novas terapias biológicas ao Sistema Único de Saúde: Avaliação logística e primeiras aplicações clínicas do transplante legalizado de membrana amniótica
A membrana amniótica humana (MA) possui propriedades imunomoduladoras e regenerativas que a tornam valiosa no tratamento de queimaduras e lesões cutâneas complexas. No Brasil, a Portaria n° 8.244, de setembro de 2025, regulamentou seu processamento e uso clínico por bancos de multitecidos. Apresentar os resultados operacionais iniciais da implementação deste novo recurso terapêutico em um banco de tecidos credenciado. Trata-se de um estudo descritivo, do tipo nota prévia, que avaliou o período de 07 de outubro a 26 de novembro de 2025, ao longo de 50 dias. Os dados operacionais (captação, processamento, distribuição) e clínicos (primeiros transplantes) foram analisados. O processamento envolveu triagem rigorosa de doadoras, tratamento antibiótico, manipulação em sala limpa com fluxo laminar com qualificação 5 da Organização Internacional de Normalização (ISO) e controle de qualidade microbiológico e sorológico. O tecido foi liberado após resultados negativos consistentes. O Banco de Tecidos Dr. Roberto Corrêa Chem (BTDRCC) captou 13 MA e alcançou 100% de conformidade microbiológica e sorológica. O volume total liberado foi de 4.157 cm2 (60% distribuídos), com um intervalo médio de 12,5 dias entre captação e liberação. O primeiro transplante legalizado de MA no Brasil foi realizado no período avaliado. Os resultados preliminares validam a viabilidade operacional e a segurança do protocolo estabelecido pelo BTDRCC, garantindo 100% de conformidade microbiológica e liberação rápida de tecido. Estes dados estabelecem a base para futuras investigações sobre os desfechos clínicos e a análise de custos do uso da MA no cenário brasileiro. Os dados serão disponibilizados mediante solicitação ao autor correspondente. Editor-chefe: Dov Charles Goldenberg. Received: 10 December 2025 Accepted: 16 December 2025 Article published online: 22 April 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
- 7 February 2026
- Published by Georg Thieme Verlag KG in Revista Brasileira de Cirurgia Plástica (RBCP) – Brazilian Journal of Plastic Surgery
- Vol. 41 (CP)
Open AccessIntegração de novas terapias biológicas ao Sistema Único de Saúde: Avaliação logística e primeiras aplicações clínicas do transplante legalizado de membrana amniótica
A membrana amniótica humana (MA) possui propriedades imunomoduladoras e regenerativas que a tornam valiosa no tratamento de queimaduras e lesões cutâneas complexas. No Brasil, a Portaria n° 8.244, de setembro de 2025, regulamentou seu processamento e uso clínico por bancos de multitecidos. Apresentar os resultados operacionais iniciais da implementação deste novo recurso terapêutico em um banco de tecidos credenciado. Trata-se de um estudo descritivo, do tipo nota prévia, que avaliou o período de 07 de outubro a 26 de novembro de 2025, ao longo de 50 dias. Os dados operacionais (captação, processamento, distribuição) e clínicos (primeiros transplantes) foram analisados. O processamento envolveu triagem rigorosa de doadoras, tratamento antibiótico, manipulação em sala limpa com fluxo laminar com qualificação 5 da Organização Internacional de Normalização (ISO) e controle de qualidade microbiológico e sorológico. O tecido foi liberado após resultados negativos consistentes. O Banco de Tecidos Dr. Roberto Corrêa Chem (BTDRCC) captou 13 MA e alcançou 100% de conformidade microbiológica e sorológica. O volume total liberado foi de 4.157 cm2 (60% distribuídos), com um intervalo médio de 12,5 dias entre captação e liberação. O primeiro transplante legalizado de MA no Brasil foi realizado no período avaliado. Os resultados preliminares validam a viabilidade operacional e a segurança do protocolo estabelecido pelo BTDRCC, garantindo 100% de conformidade microbiológica e liberação rápida de tecido. Estes dados estabelecem a base para futuras investigações sobre os desfechos clínicos e a análise de custos do uso da MA no cenário brasileiro. Os dados serão disponibilizados mediante solicitação ao autor correspondente. Editor-chefe: Dov Charles Goldenberg. Received: 10 December 2025 Accepted: 16 December 2025 Article published online: 22 April 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2026 (1)
MRI Imaging of Uterine Incarceration: From Diagnosis to Posttreatment Follow‐Up
Introduction: Uterine incarceration is a rare and frequently underrecognized obstetric complication caused by persistent retroversion of the gravid uterus. Because clinical manifestations are often nonspecific, diagnosis may be delayed, increasing the risk of maternal and fetal complications. Imaging, particularly magnetic resonance imaging (MRI), may be essential when ultrasound findings are inconclusive. Case Presentation: A 37‐year‐old multigravida with a history of recurrent pregnancy loss presented at 16 weeks′ gestation with acute urinary retention. Clinical examination raised suspicion for uterine incarceration. MRI confirmed the diagnosis by demonstrating a retroverted gravid uterus impacted within the posterior pelvis, associated with elongation and anterior displacement of the cervix and compression of the lower urinary tract. Prompt bladder decompression and successful uterine repositioning were performed, with subsequent resolution of symptoms and favorable maternal‐fetal evolution. Discussion: This case highlights the importance of correlating clinical and imaging findings in pregnant patients presenting with acute urinary symptoms. MRI was decisive in clarifying pelvic anatomy and establishing the diagnosis when sonographic evaluation was limited. Early recognition of uterine incarceration enables timely intervention and may reduce the risk of obstetric and urological complications, contributing to improved maternal‐fetal monitoring and management.
- 1 January 2026
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2026 (1)
Open AccessMRI Imaging of Uterine Incarceration: From Diagnosis to Posttreatment Follow‐Up
Introduction: Uterine incarceration is a rare and frequently underrecognized obstetric complication caused by persistent retroversion of the gravid uterus. Because clinical manifestations are often nonspecific, diagnosis may be delayed, increasing the risk of maternal and fetal complications. Imaging, particularly magnetic resonance imaging (MRI), may be essential when ultrasound findings are inconclusive. Case Presentation: A 37‐year‐old multigravida with a history of recurrent pregnancy loss presented at 16 weeks′ gestation with acute urinary retention. Clinical examination raised suspicion for uterine incarceration. MRI confirmed the diagnosis by demonstrating a retroverted gravid uterus impacted within the posterior pelvis, associated with elongation and anterior displacement of the cervix and compression of the lower urinary tract. Prompt bladder decompression and successful uterine repositioning were performed, with subsequent resolution of symptoms and favorable maternal‐fetal evolution. Discussion: This case highlights the importance of correlating clinical and imaging findings in pregnant patients presenting with acute urinary symptoms. MRI was decisive in clarifying pelvic anatomy and establishing the diagnosis when sonographic evaluation was limited. Early recognition of uterine incarceration enables timely intervention and may reduce the risk of obstetric and urological complications, contributing to improved maternal‐fetal monitoring and management.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Fisioterapia em Movimento
- Vol. 39, e39301
Pelvic girdle pain syndrome in the postpartum period
Introduction: Pelvic girdle pain (PGP) is common during pregnancy and the postpartum period, although only a minority of patients experience severe, function-limiting pain.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Fisioterapia em Movimento
- Vol. 39, e39301
Open AccessPelvic girdle pain syndrome in the postpartum period
Introduction: Pelvic girdle pain (PGP) is common during pregnancy and the postpartum period, although only a minority of patients experience severe, function-limiting pain.
- Open Access
- 21 October 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Did COVID-19 impact perinatal outcomes differently in public and private maternity hospitals in Brazil?
Objective: To compare maternal and perinatal outcomes in pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) infection among admissions in public and private maternity hospitals before COVID-19 vaccination. Methods: We performed a secondary analysis of the REBRACO (in Portuguese, the Brazilian Network of COVID-19 During Pregnancy) initiative, a national […] Abstract Objective: To compare maternal and perinatal outcomes in pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) infection among admissions in public and private maternity hospitals before COVID-19 vaccination. Methods: We performed a secondary analysis of the REBRACO (in Portuguese, the Brazilian Network of COVID-19 During Pregnancy) initiative, a national […]
- 21 October 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Open AccessDid COVID-19 impact perinatal outcomes differently in public and private maternity hospitals in Brazil?
Objective: To compare maternal and perinatal outcomes in pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) infection among admissions in public and private maternity hospitals before COVID-19 vaccination. Methods: We performed a secondary analysis of the REBRACO (in Portuguese, the Brazilian Network of COVID-19 During Pregnancy) initiative, a national […] Abstract Objective: To compare maternal and perinatal outcomes in pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) infection among admissions in public and private maternity hospitals before COVID-19 vaccination. Methods: We performed a secondary analysis of the REBRACO (in Portuguese, the Brazilian Network of COVID-19 During Pregnancy) initiative, a national […]
- Open Access
- 3 July 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Asthma and pregnancy
Key points •Asthma is the most common lung disease during pregnancy and its diagnosis is determined in the same way in pregnant and non-pregnant women. •Spirometry is a simple test used to confirm and monitor the disease, and has no contraindications for use during pregnancy both in the pre- and post-bronchodilator phase. •The control of […] Key points •Asthma is the most common lung disease during pregnancy and its diagnosis is determined in the same way in pregnant and non-pregnant women. •Spirometry is a simple test used to confirm and monitor the disease, and has no contraindications for use during pregnancy both in the pre- and post-bronchodilator phase. •The control of […]
- 3 July 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Open AccessAsthma and pregnancy
Key points •Asthma is the most common lung disease during pregnancy and its diagnosis is determined in the same way in pregnant and non-pregnant women. •Spirometry is a simple test used to confirm and monitor the disease, and has no contraindications for use during pregnancy both in the pre- and post-bronchodilator phase. •The control of […] Key points •Asthma is the most common lung disease during pregnancy and its diagnosis is determined in the same way in pregnant and non-pregnant women. •Spirometry is a simple test used to confirm and monitor the disease, and has no contraindications for use during pregnancy both in the pre- and post-bronchodilator phase. •The control of […]
- Open Access
- 30 April 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Incidence of small-for-gestational-age newborns in pregnant women with COVID-19
Objective: This study aimed to assess the incidence of small for gestational age (SGA) newborns in pregnant women infected with COVID-19 and examine the associated neonatal outcomes. Methods: This study involved a secondary analysis of the REBRACO Network, a prospective cohort study conducted in 15 maternity hospitals in Brazil before the introduction of COVID-19 […] Abstract Objective: This study aimed to assess the incidence of small for gestational age (SGA) newborns in pregnant women infected with COVID-19 and examine the associated neonatal outcomes. Methods: This study involved a secondary analysis of the REBRACO Network, a prospective cohort study conducted in 15 maternity hospitals in Brazil before the introduction of COVID-19 […]
- 30 April 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Open AccessIncidence of small-for-gestational-age newborns in pregnant women with COVID-19
Objective: This study aimed to assess the incidence of small for gestational age (SGA) newborns in pregnant women infected with COVID-19 and examine the associated neonatal outcomes. Methods: This study involved a secondary analysis of the REBRACO Network, a prospective cohort study conducted in 15 maternity hospitals in Brazil before the introduction of COVID-19 […] Abstract Objective: This study aimed to assess the incidence of small for gestational age (SGA) newborns in pregnant women infected with COVID-19 and examine the associated neonatal outcomes. Methods: This study involved a secondary analysis of the REBRACO Network, a prospective cohort study conducted in 15 maternity hospitals in Brazil before the introduction of COVID-19 […]